CNTB
Price
$2.12
Change
+$0.02 (+0.95%)
Updated
Jun 12 closing price
Capitalization
133.48M
Intraday BUY SELL Signals
INKT
Price
$12.02
Change
-$0.32 (-2.59%)
Updated
Jun 12 closing price
Capitalization
59.96M
60 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

CNTB vs INKT

Header iconCNTB vs INKT Comparison
Open Charts CNTB vs INKTBanner chart's image
CNTB vs INKT Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
CNTB vs. INKT commentary
Jun 13, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CNTB is a Hold and INKT is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 13, 2026
Stock price -- (CNTB: $2.12 vs. INKT: $12.03)
Brand notoriety: CNTB and INKT are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CNTB: 75% vs. INKT: 61%
Market capitalization -- CNTB: $133.48M vs. INKT: $59.96M
CNTB [@Biotechnology] is valued at $133.48M. INKT’s [@Biotechnology] market capitalization is $59.96M. The market cap for tickers in the [@Biotechnology] industry ranges from $112.92B to $0. The average market capitalization across the [@Biotechnology] industry is $1.9B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CNTB’s FA Score shows that 0 FA rating(s) are green whileINKT’s FA Score has 0 green FA rating(s).

  • CNTB’s FA Score: 0 green, 5 red.
  • INKT’s FA Score: 0 green, 5 red.
According to our system of comparison, INKT is a better buy in the long-term than CNTB.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CNTB’s TA Score shows that 3 TA indicator(s) are bullish while INKT’s TA Score has 4 bullish TA indicator(s).

  • CNTB’s TA Score: 3 bullish, 4 bearish.
  • INKT’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, both CNTB and INKT are a bad buy in the short-term.

Price Growth

CNTB (@Biotechnology) experienced а -2.30% price change this week, while INKT (@Biotechnology) price change was +1.39% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.78%. For the same industry, the average monthly price growth was +90.18%, and the average quarterly price growth was +2050.65%.

Reported Earning Dates

INKT is expected to report earnings on Aug 12, 2026.

Industries' Descriptions

@Biotechnology (+0.78% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CNTB($133M) has a higher market cap than INKT($60M). INKT YTD gains are higher at: 7.937 vs. CNTB (-24.823). INKT has higher annual earnings (EBITDA): -12.67M vs. CNTB (-65.54M). CNTB has more cash in the bank: 46M vs. INKT (9.53M). CNTB has less debt than INKT: CNTB (693K) vs INKT (5.73M). CNTB has higher revenues than INKT: CNTB (233K) vs INKT (0).
CNTBINKTCNTB / INKT
Capitalization133M60M222%
EBITDA-65.54M-12.67M517%
Gain YTD-24.8237.937-313%
P/E RatioN/AN/A-
Revenue233K0-
Total Cash46M9.53M483%
Total Debt693K5.73M12%
TECHNICAL ANALYSIS
Technical Analysis
CNTBINKT
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
Bullish Trend 1 day ago
81%
Bearish Trend 1 day ago
90%
Momentum
ODDS (%)
Bearish Trend 1 day ago
88%
Bearish Trend 1 day ago
90%
MACD
ODDS (%)
Bearish Trend 1 day ago
88%
Bullish Trend 1 day ago
90%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
89%
Bullish Trend 1 day ago
81%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 1 day ago
80%
Advances
ODDS (%)
Bullish Trend 1 day ago
89%
Bullish Trend 3 days ago
78%
Declines
ODDS (%)
Bearish Trend 4 days ago
88%
Bearish Trend 6 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
90%
Bearish Trend 1 day ago
90%
Aroon
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
89%
View a ticker or compare two or three
Interact to see
Advertisement
CNTB
Daily Signal:
Gain/Loss:
INKT
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
HGHCX25.36N/A
N/A
Hartford Healthcare C
PEAPX41.11N/A
N/A
Principal Glb Emerging Markets R3
TPIIX17.63N/A
N/A
Timothy Plan International I
YASSX12.62N/A
N/A
AMG Yacktman Special Opportunities I
HAOSX19.34N/A
N/A
Harbor International Core Institutional

CNTB and

Correlation & Price change

A.I.dvisor indicates that over the last year, CNTB has been loosely correlated with AMRN. These tickers have moved in lockstep 55% of the time. This A.I.-generated data suggests there is some statistical probability that if CNTB jumps, then AMRN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CNTB
1D Price
Change %
CNTB100%
+0.95%
AMRN - CNTB
55%
Loosely correlated
+2.46%
ENTA - CNTB
30%
Poorly correlated
+3.48%
INKT - CNTB
30%
Poorly correlated
-2.43%
BTAI - CNTB
26%
Poorly correlated
+4.05%
VSTM - CNTB
26%
Poorly correlated
+3.81%
More

INKT and

Correlation & Price change

A.I.dvisor indicates that over the last year, INKT has been closely correlated with REVB. These tickers have moved in lockstep 66% of the time. This A.I.-generated data suggests there is a high statistical probability that if INKT jumps, then REVB could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To INKT
1D Price
Change %
INKT100%
-2.43%
REVB - INKT
66%
Closely correlated
-1.36%
RAIN - INKT
43%
Loosely correlated
+0.96%
CYPH - INKT
42%
Loosely correlated
-4.06%
PHVS - INKT
39%
Loosely correlated
-4.60%
PTHS - INKT
37%
Loosely correlated
-4.25%
More